HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jose Bravo-Marques Selected Research

Radiotherapy

1/2019Impact of Radiation Target Volume on Health-Related Quality of Life in Patients With Low-Grade Glioma in the 2-Year Period Post Treatment: A Secondary Analysis of the EORTC 22033-26033.
11/2016Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jose Bravo-Marques Research Topics

Disease

2Glioma (Gliomas)
01/2019 - 11/2016
1Neoplasms (Cancer)
01/2019
1Fatigue
11/2016
1Infections
11/2016
1Oligodendroglioma
11/2016
1Virus Diseases (Viral Diseases)
11/2016
1HIV Infections (HIV Infection)
11/2016
1Chronic Hepatitis B
11/2016
1Astrocytoma (Pilocytic Astrocytoma)
11/2016

Drug/Important Bio-Agent (IBA)

1Temozolomide (Temodar)FDA LinkGeneric
11/2016

Therapy/Procedure

2Radiotherapy
01/2019 - 11/2016
1Drug Therapy (Chemotherapy)
11/2016
1Oral Administration
11/2016